These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. High-level potentiation of lysostaphin anti-staphylococcal activity by lysozyme. Cisani G; Varaldo PE; Grazi G; Soro O Antimicrob Agents Chemother; 1982 Apr; 21(4):531-5. PubMed ID: 7081976 [TBL] [Abstract][Full Text] [Related]
26. Detection of Staphylococcus aureus with a fluorescence in situ hybridization that does not require lysostaphin. Lawson TS; Connally RE; Iredell JR; Vemulpad S; Piper JA J Clin Lab Anal; 2011; 25(2):142-7. PubMed ID: 21438009 [TBL] [Abstract][Full Text] [Related]
30. In vitro assessment of an antibacterial quaternary ammonium-based polymer loaded with chlorhexidine for the coating of polypropylene prosthetic meshes. Pérez-Köhler B; Fernández-Gutiérrez M; Pascual G; García-Moreno F; San Román J; Bellón JM Hernia; 2016 Dec; 20(6):869-878. PubMed ID: 27590327 [TBL] [Abstract][Full Text] [Related]
31. Lysostaphin-coated catheters eradicate Staphylococccus aureus challenge and block surface colonization. Shah A; Mond J; Walsh S Antimicrob Agents Chemother; 2004 Jul; 48(7):2704-7. PubMed ID: 15215130 [TBL] [Abstract][Full Text] [Related]
32. [Topical use of lysostaphin for Staphylococcus aureus infection of burn wounds in mice]. Huan JN Zhonghua Wai Ke Za Zhi; 1992 May; 30(5):270-1, 316. PubMed ID: 1289000 [TBL] [Abstract][Full Text] [Related]
34. Expression and activity of beta-defensins and LL-37 in the developing human lung. Starner TD; Agerberth B; Gudmundsson GH; McCray PB J Immunol; 2005 Feb; 174(3):1608-15. PubMed ID: 15661923 [TBL] [Abstract][Full Text] [Related]
35. The bactericidal effect of lysostaphin coupled with liposomal vancomycin as a dual combating system applied directly on methicillin-resistant Hajiahmadi F; Alikhani MY; Shariatifar H; Arabestani MR; Ahmadvand D Int J Nanomedicine; 2019; 14():5943-5955. PubMed ID: 31447553 [TBL] [Abstract][Full Text] [Related]
36. An experimental study exploring the relationship between the size of bacterial inoculum and bacterial adherence to prosthetic mesh. Sanders DL; Kingsnorth AN; Lambie J; Bond P; Moate R; Steer JA Surg Endosc; 2013 Mar; 27(3):978-85. PubMed ID: 23052522 [TBL] [Abstract][Full Text] [Related]
37. Lysostaphin-coated titan-implants preventing localized osteitis by Staphylococcus aureus in a mouse model. Windolf CD; Lögters T; Scholz M; Windolf J; Flohé S PLoS One; 2014; 9(12):e115940. PubMed ID: 25536060 [TBL] [Abstract][Full Text] [Related]
38. [Preventive effect of polypropylene mesh bonded norvancomycin slow-release microsphere on Staphylococcus aureus infection of incisional hernia repair model]. Liu F; Gao L; Liu T; Li J; Yao S; Wang S; Zhu Y; Pei L Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2011 May; 25(5):582-6. PubMed ID: 21675118 [TBL] [Abstract][Full Text] [Related]
39. Protective roles of the skin against infection: implication of naturally occurring human antimicrobial agents beta-defensins, cathelicidin LL-37 and lysozyme. Niyonsaba F; Ogawa H J Dermatol Sci; 2005 Dec; 40(3):157-68. PubMed ID: 16150577 [TBL] [Abstract][Full Text] [Related]
40. Preclinical Bioassay of a Polypropylene Mesh for Hernia Repair Pretreated with Antibacterial Solutions of Chlorhexidine and Allicin: An In Vivo Study. Pérez-Köhler B; García-Moreno F; Brune T; Pascual G; Bellón JM PLoS One; 2015; 10(11):e0142768. PubMed ID: 26556805 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]